Sign in to fuzzto save your conversations, follow your research and come back anytime.

In the news

Strides Pharma surges 10% on USFDA EIR for Bengaluru facility

Strides Pharma's Pivot Path Divestment: Strategic Capital Play

Strides Pharma rises 2.69% after selling Pivot Path stake for ₹100 cr

Strides Pharma gets 5 USFDA observations after Bengaluru inspection

Strides Pharma Q4 profit jumps 51% to ₹129 crore

Strides Pharma Q4 profit surges 54% to ₹127 crore

Strides Pharma acquires Sandoz generic brands in Africa for $12M

Strides Pharma US unit gets closure report after USFDA inspection

Strides Pharma Q3 Results: PAT rises over 2-fold at ₹208.12 crore